Issue: 121
December | 2022
The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center, and the NIH, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1 Clinical Trial into their novel vaccine strategy. The study, published in the journal Science, shows that the vaccine had a favorable safety profile and induced the targeted response in 97% of vaccinated people.
Student ambassadors from theGW School of Medicine and Health Sciences’ Health Career Opportunity Program (HCOP) pounded the pavement for some grassroots lobbying on Capitol Hill on Dec. 8, meeting with legislators to advocate for the continuation of federal funding. Students met with Senators Tim Kaine (D-VA) and Mark Warner
(D-VA), as well as Representatives Jennifer Wexton (D-VA 10) and Donald Beyer (D-VA 08), sharing their stories.
Four survivors of life-threatening trauma gathered on Nov. 10, for the 11th annual George Washington University Hospital (GW Hospital) Trauma Survivor’s Day. The survivors honored the commitment of the Level I Trauma Center team — the doctors, nurses, physician assistants, paramedics, and others — who went to extraordinary lengths, pushing the boundaries of new technology, to save their lives.